Enko is the producer of safe and sustainable solutions for farmers. These solutions include products to resist pest and diseases on crops. Enko uses drug discovery and lab techniques to develop, test, and bring it's products to market for farmers' evolving needs. Enko's steps to discovery include in vivo testing, molecule exploration, and predictive analytics.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/27/2022 | Series C | $80MM | $xx.xx | $338.64MM | Alumni Ventures Group, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Endeavor8, Finistere Ventures, Germin8 Ventures, Novalis Lifesciences, Nufarm, Rabo Food & Agri Innovation Fund, Taher Gozal, To Ventures Food | |
Price per Share
$xx.xx
Shares Outstanding
16,459,544
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alumni Ventures Group, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Endeavor8, Finistere Ventures, Germin8 Ventures, Novalis Lifesciences, Nufarm, Rabo Food & Agri Innovation Fund, Taher Gozal, To Ventures Food
|
||||||
06/26/2020 | Series B | $49.66MM | $xx.xx | $121.23MM | Anterra Capital, Bill & Melinda Gates Foundation, Finistere Ventures, Germin8 Ventures, Novalis Lifesciences, Rabo Food & Agri Innovation Fund, To Ventures Food | |
Price per Share
$xx.xx
Shares Outstanding
22,574,546
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Anterra Capital, Bill & Melinda Gates Foundation, Finistere Ventures, Germin8 Ventures, Novalis Lifesciences, Rabo Food & Agri Innovation Fund, To Ventures Food
|
||||||
07/02/2018 | Series A-1 | $15MM | $xx.xx | $40MM | Anterra Capital, Rabo Food & Agri Innovation Fund | |
Price per Share
$xx.xx
Shares Outstanding
9,999,998
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Anterra Capital, Rabo Food & Agri Innovation Fund
|
||||||
12/01/2017 | Series A | $6MM | $xx.xx | $15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,000,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|